Daiichi Sankyo Co. Ltd.

04/06/2024 | Press release | Distributed by Public on 04/05/2024 21:31

ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors (375.5KB